Annual Book Value
$1.36 M
-$6.22 M-82.01%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual book value is $1.36 million, with the most recent change of -$6.22 million (-82.01%) on December 1, 2023.
- During the last 3 years, NBY annual book value has fallen by -$10.95 million (-88.93%).
- NBY annual book value is now -90.47% below its all-time high of $14.32 million, reached on December 31, 2007.
Performance
NBY Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$1.07 M
+$1.69 M+271.11%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly book value is $1.07 million, with the most recent change of +$1.69 million (+271.11%) on September 1, 2024.
- Over the past year, NBY quarterly book value has dropped by -$3.99 million (-78.93%).
- NBY quarterly book value is now -93.78% below its all-time high of $17.14 million, reached on March 31, 2022.
Performance
NBY Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
NBY Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -82.0% | -78.9% |
| 3 y3 years | -88.9% | -83.4% |
| 5 y5 years | -72.5% | -83.4% |
NBY Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.6% | at low | -93.8% | +180.4% |
| 5 y | 5-year | -88.9% | +40.2% | -93.8% | +180.4% |
| alltime | all time | -90.5% | +126.8% | -93.8% | +114.6% |
NovaBay Pharmaceuticals Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.07 M(-271.1%) |
| Jun 2024 | - | -$623.00 K(-53.0%) |
| Mar 2024 | - | -$1.32 M(-197.1%) |
| Dec 2023 | $1.36 M(-82.0%) | $1.36 M(-73.0%) |
| Sep 2023 | - | $5.06 M(-21.4%) |
| Jun 2023 | - | $6.44 M(+8.8%) |
| Mar 2023 | - | $5.92 M(-21.9%) |
| Dec 2022 | $7.58 M(-20.1%) | $7.58 M(-42.6%) |
| Sep 2022 | - | $13.21 M(-12.9%) |
| Jun 2022 | - | $15.18 M(-11.4%) |
| Mar 2022 | - | $17.14 M(+80.6%) |
| Dec 2021 | $9.49 M(-23.0%) | $9.49 M(+1.4%) |
| Sep 2021 | - | $9.36 M(-16.5%) |
| Jun 2021 | - | $11.21 M(+2.1%) |
| Mar 2021 | - | $10.98 M(-10.8%) |
| Dec 2020 | $12.32 M(+1166.0%) | $12.32 M(-11.3%) |
| Sep 2020 | - | $13.88 M(+1312.2%) |
| Jun 2020 | - | $983.00 K(-381.7%) |
| Mar 2020 | - | -$349.00 K(-135.9%) |
| Dec 2019 | $973.00 K(-80.4%) | $973.00 K(-66.7%) |
| Sep 2019 | - | $2.92 M(+75.1%) |
| Jun 2019 | - | $1.67 M(+47.8%) |
| Mar 2019 | - | $1.13 M(-77.2%) |
| Dec 2018 | $4.95 M(+91.0%) | $4.95 M(-18.2%) |
| Sep 2018 | - | $6.06 M(-18.4%) |
| Jun 2018 | - | $7.43 M(-16.3%) |
| Mar 2018 | - | $8.87 M(+242.0%) |
| Dec 2017 | $2.59 M(-63.5%) | $2.59 M(+41.6%) |
| Sep 2017 | - | $1.83 M(-42.9%) |
| Jun 2017 | - | $3.21 M(-26.3%) |
| Mar 2017 | - | $4.36 M(-38.7%) |
| Dec 2016 | $7.10 M(-239.3%) | $7.10 M(+5.7%) |
| Sep 2016 | - | $6.72 M(-372.3%) |
| Jun 2016 | - | -$2.47 M(-66.2%) |
| Mar 2016 | - | -$7.30 M(+43.2%) |
| Dec 2015 | -$5.10 M | -$5.10 M(-2345.8%) |
| Sep 2015 | - | $227.00 K(-95.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $4.90 M(+128.2%) |
| Mar 2015 | - | $2.15 M(+16.3%) |
| Dec 2014 | $1.85 M(-78.3%) | $1.85 M(-67.5%) |
| Sep 2014 | - | $5.69 M(-38.3%) |
| Jun 2014 | - | $9.22 M(-22.1%) |
| Mar 2014 | - | $11.84 M(+39.0%) |
| Dec 2013 | $8.52 M(-39.4%) | $8.52 M(+57.1%) |
| Sep 2013 | - | $5.42 M(-24.8%) |
| Jun 2013 | - | $7.21 M(-30.3%) |
| Mar 2013 | - | $10.34 M(-26.4%) |
| Dec 2012 | $14.05 M(+50.4%) | $14.05 M(+88.7%) |
| Sep 2012 | - | $7.44 M(+32.6%) |
| Jun 2012 | - | $5.61 M(-23.8%) |
| Mar 2012 | - | $7.37 M(-21.1%) |
| Dec 2011 | $9.34 M(-10.9%) | $9.34 M(-27.8%) |
| Sep 2011 | - | $12.94 M(+34.3%) |
| Jun 2011 | - | $9.64 M(+7.8%) |
| Mar 2011 | - | $8.94 M(-14.8%) |
| Dec 2010 | $10.49 M(-21.4%) | $10.49 M(+5.1%) |
| Sep 2010 | - | $9.98 M(-11.8%) |
| Jun 2010 | - | $11.31 M(-7.2%) |
| Mar 2010 | - | $12.19 M(-8.7%) |
| Dec 2009 | $13.35 M(+81.7%) | $13.35 M(+39.2%) |
| Sep 2009 | - | $9.59 M(+28.6%) |
| Jun 2009 | - | $7.46 M(-0.6%) |
| Mar 2009 | - | $7.50 M(+2.1%) |
| Dec 2008 | $7.34 M(-48.7%) | $7.34 M(-14.9%) |
| Sep 2008 | - | $8.63 M(-12.7%) |
| Jun 2008 | - | $9.88 M(-17.2%) |
| Mar 2008 | - | $11.93 M(-16.7%) |
| Dec 2007 | $14.32 M(+783.4%) | $14.32 M(-614.4%) |
| Sep 2007 | - | -$2.78 M(+149.7%) |
| Jun 2007 | - | -$1.11 M(-325.3%) |
| Mar 2007 | - | $495.00 K(-69.5%) |
| Dec 2006 | $1.62 M(-47.3%) | $1.62 M(-47.3%) |
| Dec 2005 | $3.08 M(+317.5%) | $3.08 M |
| Dec 2003 | $737.00 K | - |
FAQ
- What is NovaBay Pharmaceuticals annual book value?
- What is the all time high annual book value for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual book value year-on-year change?
- What is NovaBay Pharmaceuticals quarterly book value?
- What is the all time high quarterly book value for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly book value year-on-year change?
What is NovaBay Pharmaceuticals annual book value?
The current annual book value of NBY is $1.36 M
What is the all time high annual book value for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual book value is $14.32 M
What is NovaBay Pharmaceuticals annual book value year-on-year change?
Over the past year, NBY annual book value has changed by -$6.22 M (-82.01%)
What is NovaBay Pharmaceuticals quarterly book value?
The current quarterly book value of NBY is $1.07 M
What is the all time high quarterly book value for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly book value is $17.14 M
What is NovaBay Pharmaceuticals quarterly book value year-on-year change?
Over the past year, NBY quarterly book value has changed by -$3.99 M (-78.93%)